Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)	COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Neurologic Manifestations, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, Sensation Disorders, Signs and Symptoms, Smell Dysfunction, anosmia, long COVID-19, lung disorder, nervous system disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia	Recruiting	Phase 2 / Phase 3	2026-04-02		NCT05855369

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Medical University of South Carolina	262
National Institute on Deafness and Other Communication Disorders (NIDCD)	187
National Institutes of Health (NIH)	667

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Medical University of South Carolina	Charleston	United States	628